Mode of Action, Clinical Profile and Significance of Beta-Blockers in Antiglaucoma Therapy

被引：3
|
作者：
Schlote, T. [1 ]
机构：
[1] Tagesklin Ambimed, CH-4057 Basel, Switzerland
来源：
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE | 2013年 / 230卷 / 02期
关键词：
glaucoma; pharmacology; biochemistry; DIURNAL INTRAOCULAR-PRESSURE; TIMOLOL MALEATE; UNFIXED COMBINATION; FIXED COMBINATION; GLAUCOMA PATIENTS; EFFICACY; TOLERABILITY; METAANALYSIS; EXFOLIATION; SAFETY;
D O I：
10.1055/s-0032-1327784
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
Beta-blockers are among the most important groups of drugs for glaucoma therapy. The advantages of beta-blockers are a good efficacy in primary and secondary types of glaucoma, different dosages, clinical experiences over decades, easy use in combination with all other glaucoma drugs, and low costs. Timolol is the most frequently used drug in fixed glaucoma medications. In comparison with other glaucoma drugs, beta-blockers have the most severe systemic side effects and may interact with other systemic medication.
引用
收藏
页码：120 / 126
页数：7
相关论文
共 50 条
  • [31] Therapy of heart failure with beta-blockers
    Osterziel, KJ
    Dietz, R
    ZEITSCHRIFT FUR KARDIOLOGIE, 1997, 86 (01): : 1 - 8
  • [32] CLINICAL REVIEW OF BETA-BLOCKERS IN ANXIETY
    KELLY, D
    PHARMAKOPSYCHIATRIE NEURO-PSYCHOPHARMAKOLOGIE, 1980, 13 (05): : 259 - 266
  • [33] Beta-Blockers in Pregnancy: Clinical Update
    Katsi, Vasiliki
    Papakonstantinou, Ilias P.
    Papazachou, Ourania
    Makris, Thomas
    Tsioufis, Konstantinos
    CURRENT HYPERTENSION REPORTS, 2023, 25 (02) : 13 - 24
  • [34] Beta-Blockers in Pregnancy: Clinical Update
    Vasiliki Katsi
    Ilias P. Papakonstantinou
    Ourania Papazachou
    Thomas Makris
    Konstantinos Tsioufis
    Current Hypertension Reports, 2023, 25 (2) : 13 - 24
  • [35] OXIDATION PHENOTYPE AND THE METABOLISM AND ACTION OF BETA-BLOCKERS
    LENNARD, MS
    KLINISCHE WOCHENSCHRIFT, 1985, 63 (07): : 285 - 292
  • [36] Beta-blockers: Historical Perspective and Mechanisms of Action
    Oliver, Eduardo
    Mayor Jr, Federico
    D'Ocon, Pilar
    REVISTA ESPANOLA DE CARDIOLOGIA, 2019, 72 (10): : 853 - 862
  • [37] LIPOPHILIA AND CARDIOVASCULAR ACTION OF 5 BETA-BLOCKERS
    MIDOLMONNET, M
    DAVY, M
    HEIMBURGER, M
    BESLOT, F
    COHEN, Y
    JACQUOT, C
    JOURNAL DE PHARMACOLOGIE, 1985, 16 (04) : 567 - 567
  • [38] Staging therapy of acute beta-blockers poisoning
    Vucinic, S
    Todorovic, V
    Vucinic, Z
    Kosanovic, M
    Jovanovic, M
    Babic, G
    TOXICOLOGY, 2001, 164 (1-3) : 135 - 135
  • [39] EFFECT OF BETA-BLOCKERS OF THE LIPID PROFILE IN ARTERIAL HYPERTENSIVES
    ROMAN, O
    GAC, JC
    PINO, ME
    PEREDA, T
    VALENZUELA, MA
    CESPEDES, E
    REVISTA MEDICA DE CHILE, 1985, 113 (05) : 26 - 26
  • [40] Response to: A myth of ophthalmic beta-blockers therapy
    Roger C. W. Wolfs
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2009, 247 : 1723 - 1723
12345